Unilife Corporation (UNS.AX)
-ASX 0.58 
0.02(3.57%) 19 Jun 16:11
| Prev Close: | 0.56 |
|---|
| Open: | 0.56 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.56 - 0.58 |
|---|
| 52wk Range: | 0.30 - 0.79 |
|---|
| Volume: | 564,744 |
|---|
| Avg Vol (3m): | 1,063,320 |
|---|
| Market Cap: | 293.08M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in AUD.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 85.70 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Jun-13)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | 1.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Unilife Corporation designs, develops, manufactures, and commercializes injectable drug delivery systems in the United States and internationally. The companys principal product is the Unifill ready-to-fill syringe, which is designed for pha...
View More